title: Reply to L. Moreno et al.
authors.forename: Nai-Kong V
authors.initials: NK
authors.lastname: Cheung
authors.forename: Irene Y
authors.initials: IY
authors.lastname: Cheung
authors.forename: Irina
authors.initials: I
authors.lastname: Ostrovnaya
authors.forename: Brian H
authors.initials: BH
authors.lastname: Kushner
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D015474:Isotretinoin / Q000008:administration & dosage*; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D015474:Isotretinoin